Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study.

MLA

Schnabel, Renate, et al. “Selenium Supplementation Improves Antioxidant Capacity in Vitro and in Vivo in Patients with Coronary Artery Disease The SElenium Therapy in Coronary Artery Disease Patients (SETCAP) Study.” American Heart Journal, vol. 156, no. 6, Dec. 2008, p. 1201.e1-11. EBSCOhost, https://doi.org/10.1016/j.ahj.2008.09.004.

APA

Schnabel, R., Lubos, E., Messow, C. M., Sinning, C. R., Zeller, T., Wild, P. S., Peetz, D., Handy, D. E., Munzel, T., Loscalzo, J., Lackner, K. J., & Blankenberg, S. (2008). Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study. American Heart Journal, 156(6), 1201.e1-11. https://doi.org/10.1016/j.ahj.2008.09.004

Chicago

Schnabel, Renate, Edith Lubos, Claudia M Messow, Christoph R Sinning, Tanja Zeller, Philipp S Wild, Dirk Peetz, et al. 2008. “Selenium Supplementation Improves Antioxidant Capacity in Vitro and in Vivo in Patients with Coronary Artery Disease The SElenium Therapy in Coronary Artery Disease Patients (SETCAP) Study.” American Heart Journal 156 (6): 1201.e1-11. doi:10.1016/j.ahj.2008.09.004.